Header cover image

Hong Kong (HSI) Pharma Industry Analysis

UpdatedMar 18, 2024
DataAggregated Company Financials
Companies41
  • 7D6.5%
  • 3M-1.8%
  • 1Y-11.9%
  • YTD-3.2%

In the last week, the Pharma industry is up 6.5%, with Hansoh Pharmaceutical Group leading the way with a 7.8% gain. In contrast, the industry has lost 12% in the last 12 months. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Hong Kong Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 18 Mar 2024HK$468.3bHK$470.3bHK$33.3b7.7x14x1x
Wed, 14 Feb 2024HK$410.0bHK$470.9bHK$33.6b6.6x12.2x0.9x
Fri, 12 Jan 2024HK$468.4bHK$472.2bHK$33.7b7.6x13.9x1x
Sun, 10 Dec 2023HK$471.9bHK$471.9bHK$33.7b7.4x14x1x
Tue, 07 Nov 2023HK$504.4bHK$470.0bHK$32.0b7x15.8x1.1x
Thu, 05 Oct 2023HK$436.3bHK$469.5bHK$31.6b6.5x13.8x0.9x
Sat, 02 Sep 2023HK$428.9bHK$470.9bHK$31.5b6.9x13.6x0.9x
Mon, 31 Jul 2023HK$495.6bHK$446.9bHK$27.9b9.3x17.8x1.1x
Wed, 28 Jun 2023HK$500.0bHK$446.2bHK$27.6b9.6x18.1x1.1x
Fri, 26 May 2023HK$528.5bHK$449.7bHK$28.0b8.7x18.9x1.2x
Sun, 23 Apr 2023HK$566.8bHK$454.3bHK$28.8b9.1x19.6x1.2x
Tue, 21 Mar 2023HK$585.2bHK$444.5bHK$34.3b10.2x17.1x1.3x
Thu, 16 Feb 2023HK$603.4bHK$446.3bHK$35.4b10.6x17x1.4x
Sat, 14 Jan 2023HK$649.0bHK$448.5bHK$35.8b11.6x18.1x1.4x
Mon, 12 Dec 2022HK$609.9bHK$442.0bHK$34.7b10.3x17.6x1.4x
Wed, 09 Nov 2022HK$587.3bHK$436.7bHK$33.9b9.1x17.3x1.3x
Fri, 07 Oct 2022HK$523.3bHK$516.1bHK$39.3b8.1x13.3x1x
Sun, 04 Sep 2022HK$553.1bHK$521.7bHK$41.3b9.7x13.4x1.1x
Tue, 02 Aug 2022HK$587.1bHK$513.1bHK$51.9b7.9x11.3x1.1x
Thu, 30 Jun 2022HK$628.0bHK$514.3bHK$51.9b9.7x12.1x1.2x
Sat, 28 May 2022HK$580.2bHK$513.1bHK$51.7b8.8x11.2x1.1x
Mon, 25 Apr 2022HK$576.8bHK$520.0bHK$52.1b8.4x11.1x1.1x
Wed, 23 Mar 2022HK$641.8bHK$503.5bHK$47.7b8.6x13.5x1.3x
Fri, 18 Feb 2022HK$696.4bHK$498.3bHK$44.0b10x15.8x1.4x
Sun, 16 Jan 2022HK$751.8bHK$497.1bHK$43.8b9.9x17.2x1.5x
Tue, 14 Dec 2021HK$680.2bHK$496.9bHK$43.8b8.8x15.5x1.4x
Thu, 11 Nov 2021HK$679.4bHK$495.2bHK$43.3b9.6x15.7x1.4x
Sat, 09 Oct 2021HK$727.8bHK$490.5bHK$42.5b9.7x17.1x1.5x
Mon, 06 Sep 2021HK$827.4bHK$489.5bHK$42.4b11.5x19.5x1.7x
Wed, 04 Aug 2021HK$941.2bHK$489.5bHK$42.4b11.7x22.2x1.9x
Sat, 08 May 2021HK$986.8bHK$463.7bHK$30.0b13.9x32.9x2.1x
Price to Earnings Ratio

28.9x


Total Market Cap: HK$923.5bTotal Earnings: HK$32.0bTotal Revenue: HK$463.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Pharma Industry Price to Earnings3Y Average 17.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.0x which is lower than its 3-year average PE of 17.1x.
  • The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 1.00x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market1.55%
Healthcare4.12%
Pharma6.48%
Pharma6.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3692 Hansoh Pharmaceutical GroupHK$15.167.8%
+HK$6.5b
11.1%PE32.1x
1093 CSPC Pharmaceutical GroupHK$6.548.8%
+HK$6.3b
-15.6%PE11.7x
1177 Sino BiopharmaceuticalHK$3.279.7%
+HK$5.3b
-23.2%PE29.4x
3933 United Laboratories International HoldingsHK$9.6215.8%
+HK$2.4b
97.5%PE7.2x
6600 SciClone Pharmaceuticals (Holdings)HK$16.0420.8%
+HK$1.7b
44.5%PE9.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6600

HK$16.04

SciClone Pharmaceuticals (Holdings)

7D

20.8%

1Y

44.5%

3933

HK$9.62

United Laboratories International Holdings

7D

15.8%

1Y

97.5%

6622

HK$1.63

Zhaoke Ophthalmology

7D

-3.6%

1Y

-57.7%

1177

HK$3.27

Sino Biopharmaceutical

7D

9.7%

1Y

-23.2%

3692

HK$15.16

Hansoh Pharmaceutical Group

7D

7.8%

1Y

11.1%

950

HK$1.25

Lee's Pharmaceutical Holdings

7D

-3.1%

1Y

-15.0%

2877

HK$10.56

China Shineway Pharmaceutical Group

7D

20.0%

1Y

42.5%

3737

HK$1.39

Zhongzhi Pharmaceutical Holdings

7D

-2.1%

1Y

36.3%

1558

HK$10.52

YiChang HEC ChangJiang Pharmaceutical

7D

13.1%

1Y

30.2%

1011

HK$0.035

China NT Pharma Group

7D

-20.5%

1Y

-48.5%

3320

HK$5.16

China Resources Pharmaceutical Group

7D

-0.6%

1Y

-25.1%

1093

HK$6.54

CSPC Pharmaceutical Group

7D

8.8%

1Y

-15.6%

512

HK$3.65

Grand Pharmaceutical Group

7D

5.8%

1Y

-14.3%

2161

HK$0.92

JBM (Healthcare)

7D

-3.2%

1Y

0%

2552

HK$1.51

Hua Medicine (Shanghai)

7D

-3.8%

1Y

-54.5%

1652

HK$1.10

Fusen Pharmaceutical

7D

-12.0%

1Y

-15.4%